Tumour detection test kit LYOFIA®

for tumor markersserumplasma

This CYFRA 21-1 POCT Kit is based on the fluorescence immunoassay for the quantitative detection of CYFRA 21-1 in multiple samples like human serum and plasma sample by self-developed LYOFIA® system. For in vitro diagnostic use only. Summary Cytokeratin 19 (CK19) is a soluble cytokeratin fragment 21-1. Cytokeratin is an intermediate filament component that constitutes the cytoskeleton, and is found throughout human epithelial cells. At present, 20 different cytokeratins have been found. With the help of two monoclonal antibodies KS19.1 and BM19.21, the cytokeratin A white 19 fragment, which is CYFRA21-1, can be detected. Squamous cell carcinoma, also known as epidermal carcinoma, is a malignant tumor that occurs in the epidermis or adnexal cells, and the cancer cells have different degrees of keratinization. It is more common in areas covered by squamous epithelium, such as skin, mouth, lips, esophagus, cervix, vagina, etc. In addition, although some parts such as bronchi, bladder, renal pelvis, etc. are not covered by squamous epithelium, they can form squamous cell carcinoma through squamous metaplasia. Why Test CYFRA21-1? Clinically, 80-85% of lung cancer patients are non-small cell lung cancer, including squamous cell carcinoma, adenocarcinoma, large cell carcinoma, etc., and lung squamous cell carcinoma is one of the common types of non-small cell lung cancer. Serum CYFRA21-1 is one of the preferred markers for non-small cell lung cancer, and it has a high auxiliary diagnostic value for squamous cell carcinoma. The positive rate of serum CYFRA21-1 in the diagnosis of lung cancer is 63%,